Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentrated IV Nicardipine for Hypertension in Stroke/Hemorrhage Patients
NCT00325793Phase 4Unknown
- Sponsor
- OSF HealthCare
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nicardipine in hypertension (HTN) (2 arms), sponsored by OSF HealthCare. Primary endpoint: Feasibility and safety of double and triple concentrated peripheral intravenous Nicardipine. Status: unknown.
02
Drugs
nicardipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00325793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00325793.